1

Is there a protocol for use of Nasal High Flow?


Ischaki 2017, European Respiratory Review.

Ischaki proposed the following algorithm for use on patients with acute hypoxemic respiratory failure.

 
Ischaki 2017 European Respiratory Review
   
Open "Flow Matters" featuring Ischaki Take me to the PubMed abstract
 
  1. Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device. Eur Respir Rev. 2017;26(145):170028.

Adapted from above original paper; used under Creative Commons licence 4.0. MV = mechanical ventilation; SOT = standard oxygen treatment.
Please note: this material is intended exclusively for healthcare practitioners and the information conveyed constitutes neither medical advice nor instructions for use. This material should not be used for training purposes or to replace individual hospital policies or practices. Before any product use, consult the appropriate user instructions.

2

What flow rates are typical for Nasal High Flow use?


The following table lists starting flows and flow ranges used in clinical studies for Optiflow HF therapy.

Flow distress and chronic graph
 
  1. Macé J, Marjanovic N, Faranpour F, Mimoz O, Frerebeau M, Violeau M, et al. Early high–flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before–after study. Am J Emerg Med. 2019 Mar 5. [Epub ahead of print]
3

How much pressure is generated by Nasal High Flow?


Average pressure increases approximately 0.5 - 1 cmH2O per 10 L/min.


Airway Pressure Graph
 

Pressure ranges are cannula and patient dependent. For illustrative purposes only. 

  1. Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified nasal highflow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care. 2011; 39(6):1103–10.
4

How quickly does Optiflow Nasal High Flow work?


Sztrymf associated Optiflow HF therapy with sustained beneficial effects on oxygenation and physiological
parameters for patients with acute respiratory failure. Similarly Rittayamai showed significant improvement
in post-extubation patients. These studies may provide guidance on patient responses to the therapy.
 

Optiflow
   
  1. Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of High-Flow Nasal Cannula for Acute Dyspnea and Hypoxemia in the Emergency Department. Respir Care. 2015; 60(10):1377–82.
5

Is there a bedside tool to predict the outcome of Nasal High Flow?


The validated ROX index predicts failure in adults with AHRF receiving NHF.

4 time intervals are observed: 2, 6, 12 and >12 hours. It's an easy-to-use dynamic bedside tool.
 

Calculating a ROX score
 
Open ROX clinical presentation Take me to the Pubmed abstract
 
  1. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernandez G, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High Flow Therapy. Am J Respir Crit Care Med. 2018 Dec 21. [Epub ahead of print]
6

Who does Nasal High Flow work on?


The short answer is spontaneously breathing patients with, or at risk of respiratory distress.


Is your patient presenting with:
 

patient-bed
LOW 

SpO2

patient-bed
HIGH 

PaCO2

patient-bed
HIGH 

Respiratory Rate

patient-bed
HIGH 

Work of Breathing

patient-bed
Dyspnea

 
patient-bed

The key to really understanding who can benefit from HF is in understanding the mechanisms of HF. 


 

 
7

What effect does low humidity have on the airway?


Optiflow High Flow airway hydration mechanism overview

 
 

Even a 10% drop in humidity (in the airway) can have a detrimental effect on mucociliary clearance transport, a crucial part of the upper airway defense system.

What next?


F&P Optiflow™+ Nasal Cannula

 
Optiflow™ Nasal High Flow at the Royal Berkshire Hospital

Introducing Optiflow to the Royal Berkshire Hospital

 

Please enter your details below and an F&P representative will contact you.
Contact Details
Please select from the following options:*

By submitting your personal information, you are consenting to F&P Healthcare storing your personal information to contact you regarding your enquiry. Please note, F&P will not share or disclose your information to other third parties for marketing purposes. We may share your personal data with our group company headquarters in New Zealand. For information about how we use and manage your personal information, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.

Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.
 

Sign up here